Publicaciones en las que colabora con ANTONIO LALUEZA BLANCO (14)

2022

  1. An Early Th1 Response Is a Key Factor for a Favorable COVID-19 Evolution

    Biomedicines, Vol. 10, Núm. 2

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Effective Natural Killer Cell Degranulation Is an Essential Key in COVID-19 Evolution

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  4. Shorter telomere length is associated with COVID-19 hospitalization and with persistence of radiographic lung abnormalities

    Immunity and Ageing, Vol. 19, Núm. 1

2021

  1. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID

    Biomedicines, Vol. 9, Núm. 11

  2. Alterations in circulating monocytes predict covid-19 severity and include chromatin modifications still detectable six months after recovery

    Biomedicines, Vol. 9, Núm. 9

  3. Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019

    ACR Open Rheumatology, Vol. 3, Núm. 4, pp. 267-276

  4. Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome

    Frontiers in Immunology, Vol. 12

  5. Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

    International Journal of Infectious Diseases, Vol. 105, pp. 487-494

  6. Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study

    International Journal of Infectious Diseases, Vol. 105, pp. 319-325

  7. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

  8. SARS-CoV-2-specific T-cell responses after COVID-19 recovery in patients with rheumatic diseases on immunosuppressive therapy

    Seminars in Arthritis and Rheumatism, Vol. 51, Núm. 6, pp. 1258-1262

  9. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression

    Frontiers in Cellular and Infection Microbiology, Vol. 11

2013

  1. Miltefosine-induced acute interstitial pneumonitis in a patient with renal dysfunction

    International Journal of Infectious Diseases